Related by context. Frequent words. (Click for all words.) 64 subanalysis 62 Immunogenicity 61 #th Annual Interscience 60 Pharmacokinetic 60 Arch Neurol 60 Clinical Trial Results 60 subgroup analyzes 60 Pivotal Phase III 60 SABCS 59 Adalimumab 59 virologic response 59 prospectively defined 59 Meta Analysis 59 mRCC 59 pharmacokinetic PK 58 Phase III Clinical Trial 58 Arch Intern Med 58 sustained virologic response 58 Diabetic Macular Edema 58 Phase 2a trial 58 PRECiSE 58 iclaprim 58 NHANES III 58 Amrubicin 58 Dasatinib 58 J Natl Cancer Inst 58 substudy 58 mg kg dose 58 HER2 positive metastatic breast 58 Diabetologia 57 Natalizumab 57 placebo controlled studies 57 Phase IIa trial 57 mcg dose 57 Pivotal Phase 57 #:#-# [029] 57 placebo controlled clinical trials 57 Pirfenidone 57 neoadjuvant therapy 57 Antihypertensive 57 Rosuvastatin 57 Monotherapy 57 metastatic castration resistant 57 virologic 57 NOXAFIL 57 phase IIa 57 phase IIb clinical 57 Phase III Trial 57 pharmacokinetic studies 57 Solid Tumors 57 heavily pretreated 57 ALLHAT 57 Benign Prostatic Hyperplasia 57 Phase Ib clinical 56 placebo controlled trials 56 active comparator 56 Overactive Bladder 56 Multicenter 56 lumiracoxib 56 Postmenopausal Women 56 #:#-# [033] 56 randomized Phase III 56 tocilizumab 56 pharmacokinetics PK 56 Currency Majors Technical 56 forodesine 56 phase 2a 56 Enoxaparin 56 Phase 2b study 56 Secondary endpoints 56 Carfilzomib 55 Gastrointestinal Cancers Symposium 55 Aliskiren 55 placebo controlled clinical 55 Study Demonstrates 55 Molecular Cancer 55 Traficet EN 55 J Clin Oncol 55 SPIRIT IV 55 Phase 2a clinical 55 ASH Annual Meeting 55 Acute Myocardial Infarction 55 aclidinium 55 multicenter Phase 55 ASCO Annual Meeting 55 nonrandomized 55 TRITON TIMI 55 liver transplant recipients 55 HuMax CD# 55 Phase 1b trial 55 pharmacodynamic effects 55 virologic failure 55 CAVEATS 55 alteplase 54 secondary efficacy endpoints 54 REMICADE ® 54 Arch Pediatr Adolesc Med 54 histopathological 54 Phase Ib 54 BCX# 54 Clinical Oncology Annual Meeting